These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20510223)

  • 21. [Coronary heart disease patient after myocardial infarct. Must LDL cholesterol now be reduced to 70 mg/dl?]].
    MMW Fortschr Med; 2005 Dec; 147(49-50):17-8. PubMed ID: 16401004
    [No Abstract]   [Full Text] [Related]  

  • 22. Statin utilisation--recognising the role of the invisible hand.
    Minhas R
    Int J Clin Pract; 2007 Jan; 61(1):3-6. PubMed ID: 17229171
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome.
    Chyrchel M; Rakowski T; Rzeszutko L; Legutko J; Dziewierz A; Dubiel JS; Dudek D
    Kardiol Pol; 2006 Dec; 64(12):1357-62; discussion 1363. PubMed ID: 17206539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Early initiation of statin therapy in patients with acute myocardial infarction after successful percutaneous coronary intervention].
    Katayama N; Nakao K; Horiuchi K; Ogawa H; Honda T
    J Cardiol; 2004 Oct; 44(4):131-40. PubMed ID: 15532243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total cardiovascular disease burden: comparing intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial.
    Tikkanen MJ; Szarek M; Fayyad R; Holme I; Cater NB; Faergeman O; Kastelein JJ; Olsson AG; Larsen ML; Lindahl C; Pedersen TR;
    J Am Coll Cardiol; 2009 Dec; 54(25):2353-7. PubMed ID: 20082922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Statines for all or individualized lipid lowering therapy?].
    Parhofer K
    MMW Fortschr Med; 2009 Apr; 151(14):100, 102-4; quiz 105. PubMed ID: 19504849
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment with statins in high-risk patients: relevance of time to titration of dose and adverse outcomes.
    Thadani U
    Am J Cardiovasc Drugs; 2009; 9(3):211-2; author reply 212. PubMed ID: 19463025
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of gender on statin efficacy.
    Dale KM; Coleman CI; Shah SA; Patel AA; Kluger J; White CM
    Curr Med Res Opin; 2007 Mar; 23(3):565-74. PubMed ID: 17355737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early statin therapy in patients with acute coronary syndrome.
    Liberopoulos EN; Daskalopoulou SS; Mikhailidis DP
    Hellenic J Cardiol; 2005; 46(1):5-8. PubMed ID: 15807388
    [No Abstract]   [Full Text] [Related]  

  • 31. Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates.
    Baessler A; Fischer M; Huf V; Mell S; Hengstenberg C; Mayer B; Holmer S; Riegger G; Schunkert H
    Int J Cardiol; 2005 May; 101(2):293-8. PubMed ID: 15882678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of single agent, uptitration and switching statin treatment strategies for lipid lowering in Sweden.
    Martikainen JA; Soini E; Paulsson T
    Curr Med Res Opin; 2010 Feb; 26(2):389-96. PubMed ID: 20001451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pleiotropic effects of statins].
    Palomäki A
    Duodecim; 2004; 120(4):411-8. PubMed ID: 15065459
    [No Abstract]   [Full Text] [Related]  

  • 35. Intensive statin therapy in coronary artery disease: is lower cholesterol better and safe?
    Seshasai SR; Ray KK
    Future Cardiol; 2009 Mar; 5(2):129-39. PubMed ID: 19371188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial.
    Mark DB; Knight JD; Cowper PA; Davidson-Ray L; Anstrom KJ
    Am Heart J; 2008 Oct; 156(4):698-705. PubMed ID: 18926150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
    Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lower, lower, lower. The LDL goal value of 200 mg/dl is still much too high].
    Einecke D
    MMW Fortschr Med; 2004 Mar; 146(13):4-5. PubMed ID: 15219114
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and safety of mipomersen, an antisense inhibitor of apolipoprotein B, in hypercholesterolemic subjects receiving stable statin therapy.
    Akdim F; Stroes ES; Sijbrands EJ; Tribble DL; Trip MD; Jukema JW; Flaim JD; Su J; Yu R; Baker BF; Wedel MK; Kastelein JJ
    J Am Coll Cardiol; 2010 Apr; 55(15):1611-8. PubMed ID: 20378080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial.
    Murphy SA; Cannon CP; Wiviott SD; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2009 Dec; 54(25):2358-62. PubMed ID: 20082923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.